Maintenance Treatment for Prevention of Smoking Relapse

NCT00063323 Phase 3 COMPLETED

The purpose of this study is to determine the efficacy and cost-effectiveness of long-term pharmacotherapy (using Zyban and/or nicotine replacement) for reducing the relapse rate associated with stopping smoking.

Details

Lead sponsor	National Institute on Drug Abuse (NIDA)
Phase	Phase 3
Status	COMPLETED
Enrolment	589
Start date	2000-08
Completion	2006-07

Conditions

• Tobacco Use Disorder

Interventions

• Bupropion

Primary outcomes

• Survival abstinence rate with maintenance treatment — 48 weeks after start of treatment

Countries

United States